Transcend Capital Advisors LLC Has $323,000 Stake in Cardinal Health, Inc. (NYSE:CAH)

Transcend Capital Advisors LLC grew its holdings in Cardinal Health, Inc. (NYSE:CAH) by 3.6% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 2,735 shares of the company’s stock after acquiring an additional 96 shares during the period. Transcend Capital Advisors LLC’s holdings in Cardinal Health were worth $323,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Mirae Asset Global Investments Co. Ltd. lifted its position in shares of Cardinal Health by 35.2% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 32,520 shares of the company’s stock valued at $3,871,000 after buying an additional 8,471 shares during the last quarter. CHURCHILL MANAGEMENT Corp increased its stake in shares of Cardinal Health by 1.5% during the fourth quarter. CHURCHILL MANAGEMENT Corp now owns 240,422 shares of the company’s stock worth $28,435,000 after purchasing an additional 3,576 shares during the period. Geode Capital Management LLC increased its stake in shares of Cardinal Health by 0.7% during the third quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company’s stock worth $633,298,000 after purchasing an additional 42,082 shares during the period. Consolidated Planning Corp increased its stake in shares of Cardinal Health by 40.0% during the fourth quarter. Consolidated Planning Corp now owns 8,926 shares of the company’s stock worth $1,056,000 after purchasing an additional 2,552 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its stake in shares of Cardinal Health by 2.3% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,474,625 shares of the company’s stock worth $162,976,000 after purchasing an additional 33,388 shares during the period. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Stock Performance

Shares of CAH opened at $126.96 on Monday. Cardinal Health, Inc. has a 52-week low of $93.17 and a 52-week high of $132.84. The business’s fifty day moving average is $123.62 and its 200-day moving average is $117.33. The firm has a market cap of $30.67 billion, a price-to-earnings ratio of 23.69, a PEG ratio of 1.49 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. As a group, research analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be issued a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a dividend yield of 1.59%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health’s dividend payout ratio (DPR) is 37.69%.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the company. Morgan Stanley increased their target price on Cardinal Health from $136.00 to $142.00 and gave the stock an “overweight” rating in a research note on Friday, January 31st. Deutsche Bank Aktiengesellschaft increased their target price on Cardinal Health from $119.00 to $124.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. JPMorgan Chase & Co. increased their target price on Cardinal Health from $142.00 to $145.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. Argus set a $148.00 target price on Cardinal Health in a research note on Tuesday, February 4th. Finally, Citigroup increased their target price on Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a research note on Friday, January 10th. Four analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $138.40.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.